跳至主要内容
临床试验/NCT02436226
NCT02436226已完成4 期

Use of Low Dose of Human Chorionic Gonadotropin During Ovulation Induction With Clomiphene Citrate in Women With Clomiphene Citrate Resistant Polycystic Ovarian Syndrome

Mohamed Sayed Abdelhafez1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2016年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
300
试验地点
1
主要终点
Ovulation rate

研究概览

简要总结

The purpose of this study is to evaluate the effect of administration of low dose of human chorionic gonadotropin (HCG) after use of clomiphene citrate (CC) for induction of ovulation in infertile women having CC resistant polycystic ovarian syndrome (PCOS).

详细描述

Women will be randomly divided into two groups; CC-HCG group and CC group. Women in the CC-HCG group will receive CC (150 mg/day for 5 consecutive days from day 2 of cycle) and HCG (200 IU/day SC from day 7 of cycle). Women in the CC group will receive CC alone (150 mg/day for 5 consecutive days from day 2 of cycle). Transvaginal sonography (TVS) scan will be performed regularly for monitoring of follicular growth (folliculometry); starting from day 10 of the stimulation cycle and repeated every 2-3 days. When there will be at least one follicle ≥ 18 mm in diameter, final oocyte maturation will be induced by intramuscular administration of 10000 IU of HCG and timed intercourse will be advised. If there will be no follicle ≥ 12 mm by day 16 of the cycle, monitoring of follicular growth will be discontinued and the cycle will be presumed to be anovulatory. Ovulation will be documented by TVS scan one week after triggering of oocyte maturation and will be confirmed by assessing the midluteal serum progesterone level. Each woman will be subjected to ovarian stimulation for a maximum of 3 consecutive cycles except if she gets pregnant in the first or second cycle

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Infertile lean women with PCOS as defined by the Rotterdam criteria.
  • CC resistance (defined as failure of ovulation after receiving 150 mg/day of CC for 5 consecutive days per cycle, for at least 3 consecutive cycles).

排除标准

  • Age < 20 or > 35 years.
  • Presence of any infertility factor other than anovulatory PCOS.
  • Previous history of ovarian surgery or surgical removal of one ovary.
  • Previous exposure to cytotoxic drugs or pelvic irradiation.
  • Oral hypoglycemic or hormonal therapy either currently or in the preceding 3 months.
  • Metabolic or hormonal abnormalities.

研究组 & 干预措施

Clomiphene citrate-HCG group

Active Comparator

Women will receive clomiphene citrate and human chorionic gonadotropin (HCG)

干预措施: Clomiphene citrate and Human chorionic gonadotropin (HCG) (Drug)

Clomiphene citrate group

Active Comparator

Women will receive clomiphene citrate alone

干预措施: Clomiphene citrate (Drug)

结局指标

主要结局

Ovulation rate

时间窗: 3 months

Number of ovulatory cycles divided by the number of stimulation cycles

次要结局

  • Number of ovarian follicles ≥ 18 mm on day of triggering of oocyte maturation(3 months)
  • Endometrial thickness on day of triggering of oocyte maturation(3 months)
  • Clinical pregnancy rate(6-8 weeks gestational age)
  • Incidence of early ovarian hyperstimulation syndrome (OHSS)(Within 9 days of final triggering of oocyte maturation)

研究者

发起方
Mohamed Sayed Abdelhafez
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Mohamed Sayed Abdelhafez

Dr

Mansoura University

研究点 (1)

Loading locations...

相似试验